Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: An initial survey

American Journal on Addictions

Volumn 21, Issue 3, 2012, Pages 199-201

  Jones, Hendrée E ^a,b  

^a RTI INTERNATIONAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPOTREX; METHADONE; NALTREXONE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; DRUG DOSAGE FORM COMPARISON; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; WITHDRAWAL SYNDROME;

ADULT; ALCOHOLISM; FEMALE; HUMANS; INFANT, NEWBORN; NALTREXONE; NARCOTIC ANTAGONISTS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN;

EID: 84859862167     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00229.x     Document Type: Article

References (5)

1. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998;25:139-151. (Pubitemid 28141705)
2. Jones HE, Kaltenbach K, Heil S, et al. Neonatal abstinence syndrome following methadone or buprenorphine exposure.NEngl J Med. 2010;363:2320-2331.
3. Farid WO, Dunlop SA, Tait RJ, et al. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: Review of human and animal data. Curr Neuropharmacol. 2008;62: 125-150. (Pubitemid 352024797)
4. O'Brien C, Cornish JW. Naltrexone for probationers and parolees. J Subst Abuse Treat. 2006;31:107-111. (Pubitemid 44223912)
5. McLaughlin PJ, Tobias SW, Lang CM, et al. Opioid receptor blockade during prenatal life modifies postnatal behavioral development. Pharmacol Biochem Behav. 1997;58:1075-1082. (Pubitemid 28108218)